A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure
Related Experiment Video
Updated: Nov 15, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Shotaro Ito1, Hajime Asahina1, Naoko Yamaguchi2
1Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.
Abstract:
SMARCA4-deficient thoracic sarcomatoid tumors were characterized by inactivating mutations of SMARCA4 and often found in the chest of young and middle-aged males with a smoking history. Recently, SMARCA4-deficient thoracic sarcomatoid tumors were reported to represent primarily smoking-associated undifferentiated/de-differentiated carcinomas rather than primary thoracic sarcomas. The main complication of this tumor is compression of the respiratory tract and/or blood vessels. A 39-year-old man presented with a 2-month history of fever and dyspnea. Computed tomography revealed a mediastinal tumor invading the right and left pulmonary arteries. Because of severe right heart failure, we considered him ineligible for bronchoscopy. We scheduled palliative irradiation with 40 Gy/20 Fr to improve hemodynamics and perform endobronchial ultrasound transbronchial needle aspiration later. However, irradiation was ineffective, and his general condition deteriorated quickly and he died after a 7-week hospitalization. An autopsy revealed that the diagnosis was SMARCA4-deficient thoracic undifferentiated carcinoma. It has been reported that this tumor is insensitive to radiotherapy and there were some cases which responded to an immune checkpoint inhibitor. Therefore, when caring for patients with mediastinal tumors that invade and compress the trachea and large vessels, it is important to consider this tumor as a differential diagnosis and try to make a pathological diagnosis as soon as possible.
Insights
SMARCA4-deficient thoracic undifferentiated carcinoma, a rare cancer linked to smoking, often presents as a mediastinal mass. This aggressive tumor can compress vital structures, and is typically resistant to radiation therapy.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- SMARCA4-deficient thoracic sarcomatoid tumors are increasingly recognized as smoking-associated undifferentiated/dedifferentiated carcinomas, distinct from primary thoracic sarcomas.
- These tumors are characterized by inactivating mutations in the SMARCA4 gene and predominantly affect middle-aged males with a history of smoking.
Observation:
- A case study details a 39-year-old male with a mediastinal tumor causing respiratory and vascular compression, leading to severe right heart failure.
- Initial palliative radiotherapy was ineffective, and the patient's condition rapidly declined, resulting in death within 7 weeks of hospitalization.
Findings:
- Autopsy confirmed the diagnosis as SMARCA4-deficient thoracic undifferentiated carcinoma.
- This tumor subtype demonstrates resistance to radiotherapy, highlighting the need for alternative treatment strategies.
Implications:
- Early and accurate pathological diagnosis is crucial for managing SMARCA4-deficient thoracic undifferentiated carcinoma, especially in cases of mediastinal mass with vascular or airway compression.
- Considering immune checkpoint inhibitors may be beneficial, as some cases have shown response to this therapy, warranting further investigation.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

